United States v. Lillian Akwuba

7 F.4th 1299
CourtCourt of Appeals for the Eleventh Circuit
DecidedAugust 11, 2021
Docket19-12230
StatusPublished
Cited by12 cases

This text of 7 F.4th 1299 (United States v. Lillian Akwuba) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Lillian Akwuba, 7 F.4th 1299 (11th Cir. 2021).

Opinion

USCA11 Case: 19-12230 Date Filed: 08/11/2021 Page: 1 of 36

[PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT ________________________

No. 19-12230 ________________________

D.C. Docket No. 2:17-cr-00511-SLB-GMB-1

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

LILLIAN AKWUBA,

Defendant - Appellant.

________________________

Appeal from the United States District Court for the Middle District of Alabama ________________________

(August 11, 2021)

Before WILSON, ROSENBAUM, and ED CARNES, Circuit Judges.

WILSON, Circuit Judge:

Defendant-Appellant Lillian Akwuba was convicted by a jury in the Middle

District of Alabama for conspiring to distribute and distributing controlled USCA11 Case: 19-12230 Date Filed: 08/11/2021 Page: 2 of 36

substances, in violation of 21 U.S.C. §§ 846, 841, and conspiring to commit and

committing health care fraud, in violation of 18 U.S.C. §§ 1349, 1347. Ms.

Akwuba’s conviction was the result of a large governmental investigation into a

“pill mill” run by Dr. Gilberto Sanchez. At the time of her trial, 15 people who

worked with Dr. Sanchez as doctors, nurses, and office administrators had been

indicted. Two individuals had their charges dropped, and 12 others pled guilty. Ms.

Akwuba was the only individual charged to proceed to trial. The district court

sentenced her to 120 months in prison for each count, to run concurrently. On

appeal, Ms. Akwuba raises various challenges to a jury instruction, evidentiary

rulings, and the sufficiency of the evidence.

FACTUAL AND PROCEDURAL OVERVIEW

Ms. Akwuba was convicted of issuing and conspiring to issue prescriptions

for controlled substances improperly, conspiring to commit health care fraud, and

committing health care fraud through her practice as a nurse practitioner (NP).1

Alabama law provides that an NP can prescribe controlled substances if the

NP obtains a Qualified Alabama Controlled Substance Certificate (QACSC) from

the Alabama Board of Medical Examiners (ABME). To obtain a QACSC, the

ABME requires NPs to have a collaborative agreement with a physician. During

1 Ms. Akwuba was also charged with money laundering and conspiracy to commit money laundering, in violation of 18 U.S.C. §§ 1957, 1956(h). The jury found her not guilty of those counts, and they are not at issue on appeal. 2 USCA11 Case: 19-12230 Date Filed: 08/11/2021 Page: 3 of 36

the timeframe relevant to this case, Ms. Akwuba worked with four different

collaborative physicians: Dr. Sanchez, Dr. Jose Chung, Dr. John MacLennon, and

Dr. Viplove Senadhi. Dr. Sanchez was Ms. Akwuba’s collaborative physician

during her employment at his medical practice, Family Practice. Doctors Chung,

MacLennon, and Senadhi were Ms. Akwuba’s collaborative physicians at her own

primary care practice, Mercy Family. Dr. Sanchez pled guilty and was one of the

primary witnesses in the government’s case-in-chief. Doctors MacLennon and

Senadhi also testified as government witnesses. Dr. Chung was not called as a

witness by either party.

Most of the counts Ms. Akwuba faced pertain to the time she spent working

under Dr. Sanchez at Family Practice. Ms. Akwuba left Family Practice in March

2016, and one month later she formed her own medical practice, Mercy Family.

Some of the patients Ms. Akwuba saw at Family Practice followed her to Mercy

Family. Additional drug distribution counts relate to prescriptions she issued at

Mercy Family. The drug distribution and health care fraud counts were tied to

specific patients, the records of whom were presented at trial and formed the basis

of the expert testimony.

The government presented expert testimony from three doctors at trial: Dr.

Gary Kaufman, Dr. Robert Odell, and Dr. Gene Kennedy. Each doctor reviewed

files for specific patients—including each patient’s Prescription Drug Monitoring

3 USCA11 Case: 19-12230 Date Filed: 08/11/2021 Page: 4 of 36

Program (PDMP) report 2—and testified to their conclusions based on those patient

files. Based on the documentation made available to them, the experts concluded

that the prescriptions were not issued for legitimate medical purposes. The doctors

repeatedly testified that there was nothing in the available records to support

diagnoses that would require controlled substances.

In response, Ms. Akwuba asserted an “incomplete records” defense.

Through her own testimony and the cross-examination of government witnesses,

she and her counsel raised issues regarding the patient files relied on by the expert

witnesses. As Ms. Akwuba explained to the court, “part of our defense is that these

records we’re relying on are incomplete. And these incomplete records thus form

the basis of the experts’ opinions.” Ms. Akwuba testified that she kept additional

handwritten paper records—triage sheets or “T-sheets”—which contained her

patient visit notes; if these notes were examined in addition to the electronic

records, she argued, the expert witnesses could have—and should have—reached a

different conclusion regarding the legitimacy of the prescriptions in question.

After 11 days of testimony, the counts were submitted to a jury and they

returned a verdict of guilty for: distribution of controlled substances in violation of

2 The PDMP is a database that records controlled substances that are dispensed in Alabama. PDMP records reflect what substances were actually provided to the patient through pharmacies; not just those that were prescribed. Providers can access their PDMP to see what substances a patient has received previously and for a record of how many controlled substance prescriptions all of their patients have filled. 4 USCA11 Case: 19-12230 Date Filed: 08/11/2021 Page: 5 of 36

21 U.S.C. § 841(a)(1) (Counts 2–7, 9–11, 44–48, 50–53); conspiracy to distribute

controlled substances in violation of 21 U.S.C. § 846 (Count 1); health care fraud

in violation of 18 U.S.C. § 1347 (Counts 15, 17, 22, 24); and conspiracy to commit

health care fraud in violation of 18 U.S.C. § 1349 (Count 13). Ms. Akwuba’s

convictions under Counts 44–48 and 50–53, for distribution of controlled

substances, arise from her time operating Mercy Family. All remaining counts

pertain to her time spent at Family Practice. Ms. Akwuba was sentenced to 120

months’ imprisonment on each count, to run concurrently, followed by 3 years of

supervised release. Ms. Akwuba timely appealed.

DISCUSSION

I. Sufficiency of the Evidence

We begin with sufficiency of the evidence, because only if the evidence is

sufficient to support the jury’s guilty verdicts do we have to determine whether a

trial error requires reversal and remand for a new trial. See United States v. Mount,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
7 F.4th 1299, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-lillian-akwuba-ca11-2021.